About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials | 6,413 Studies Recruiting

Clinical TrialsColorectal Cancer

Colorectal Cancer Clinical Trials

Browse 6,413 clinical trials for colorectal cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2421-2440 of 6,413 trials

CompletedRole of the MET Oncogene in Human Colorectal Cancer - A Translational StudyThe MET oncogene is known to sustain the Trousseau's syndrome in murine experimental models, featuring association of carcinogenesis with a blood procoagulant disorder.NCT02238821·Candiolo, TO UnknownSurefire Infusion System vs. Standard Microcatheter Use During Holmium-166 RadioembolizationThe objective of the SIM trial is to investigate whether using the Surefire Infusion System during holmium-166 radioembolization increases the posttreatment tumor to non-tumor…NCT02208804·Utrecht Enrolling by invitationCOLORECTAL CANCER: SINGLE CENTER EXPERIENCEcolorectal cancer: single center experienceNCT07576049·Roma RecruitingEvaluation of Skin Tests in Biotherapy AllergiesBiotherapies are biological (extracted from an organism or living tissue) or biotechnological drugs used in the treatment of multiple conditions, such as autoimmune inflammatory…NCT06971848·Angers

Related Searches

colon cancertrials rectal cancertrials

Data from ClinicalTrials.govTerms

Active not recruitingA Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal CancerThis is a multi-site, open-label, Phase II, randomized, trial to compare the efficacy of RO7198457 versus watchful waiting in patients with circulating tumor DNA (ctDNA) positive…NCT04486378·Greenbrae, California and 84 others

CompletedSelumetinib and Cetuximab in Treating Patients With Refractory Solid TumorsThis phase I trial is studying the side effects and the best dose of MEK Inhibitor AZD6244 when given together with cetuximab in patients with advanced or refractory solid tumors…NCT01217450·Bethesda, Maryland and 2 others

TerminatedLoperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over StudyClinical experience show limited effect of the drug Loperamide used to decrease output in stoma patients.NCT02266849·Odense

CompletedAn Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal CancerThe purpose of this study is to predict response to Erbitux as a single agent in patients with metastatic colon cancerNCT00207155·Duarte, California and 13 others

CompletedPhase II Study of Minocycline for Reducing Symptom Burden in Colorectal PatientsThe goal of this clinical research study is to learn if minocycline can reduce numbness, pain, and/or loss of motor function in patients with colorectal cancer.NCT01906008·Houston, Texas and 1 other

RecruitingLocal Cecal Cancer - Optimization of Surgical TreatmentThe purpose of this study is to determine the clinical efficacy, safety, and oncologic outcomes of ileocecal resection (ICR) with D3 lymphadenectomy compared to standard right…NCT06121089·Moscow

WithdrawnCetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal CancerRATIONALE: Monoclonal antibodies, such as cetuximab and bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00571740

CompletedEffectiveness of a Psychosocial Intervention for Colorectal CancerStudies have reported about one-third to half of advanced cancer patients experience psychological distress yet the mental healthcare needs of these patients are not properly…NCT03258450·Singapore

CompletedThe Exercise And Colorectal Cancer Treatment TrialThis study will examine the biologic processes through which exercise may prevent disease recurrence in patients who have completed treatment for colorectal cancer.NCT03975491·Baton Rouge, Louisiana

Active not recruitingEvaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsThis study will evaluate safety, pharmacodynamics and biomarkers of subcutaneous (SC) DK210(EGFR) given as monotherapy and in combination with immunotherapy, chemotherapy or…NCT05704985·Duarte, California and 6 others

CompletedFOcUs on Colorectal CAncer oUtcomes: Long-Term StudyColorectal cancer (CRC) affects men and women of all racial and ethnic groups and accounts for more than 600,000 deaths per year, globally.NCT03965325·Strasbourg

CompletedC-Reactive Protein and Sodium in Predicting Anastomotic LeakageAnastomotic leakage is serious morbidity that can develop in patients operated on for colorectal cancer and can reach potentially life-threatening dimensions.NCT04717648·Izmir

UnknownSintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver MetastasisTo evaluate the safety and efficacy of sintilimab combined with regorafenib and HAIC in patients with colorectal liver metastasis who failed second-line therapyNCT05524155

RecruitingA Translational Study for Locoregional Recurrence of T4 Colon CancerThe outcome of T4 locally advanced colon cancer is poor when locoregional recurrence occurred.NCT06958926·Hsinchu

WithdrawnCirculating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal CancerThe purpose of this study is to use the SignateraTm assay created from rectal tumor biopsies to monitor participants' blood for fragments of DNA shed by tumor cells.NCT05356585·Cleveland, Ohio

CompletedA Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination ChemotherapyThe purpose of the study is to assess the safety and tolerability of GC1118 in combination with irinotecan or FOLFIRI in order to determine the maximum tolerated dose (MTD) and…NCT03454620·Gyeonggi-do and 5 others

PreviousPage 122 of 321Next